McKechnie Duncan, EVP and Chief Commercial Officer at Vertex Pharmaceuticals ($VRTX), sold about $4.9 million worth of company shares on the open market in four transactions over the last year. His most recent sale occurred on March 11, 2026. These sales rank 1,977th among 11,678 insiders in our database, where the average is about $8.6 million across roughly 6.4 transactions per person. Duncan made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2633 | $498.42 | 12,489.0000 | 258,000,000 | 17.41% | 0.00% |
| March 4, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2437 | $475.30 | 15,122.0000 | 258,000,000 | 13.88% | 0.00% |
| Feb. 25, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2500 | $486.35 | 19,969.0000 | 258,000,000 | 11.13% | 0.00% |
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 873 | $485.11 | 22,469.0000 | 258,000,000 | 3.74% | 0.00% |
| Feb. 25, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | S | Common Stock | 2410 | $489.00 | 17,559.0000 | 258,000,000 | 12.07% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 1148 | $483.75 | 23,342.0000 | 258,000,000 | 4.69% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | A | Common Stock | 4962 | $0.00 | 24,490.0000 | 258,000,000 | 25.41% | 0.00% |
| Feb. 13, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 2283 | $487.76 | 19,528.0000 | 258,000,000 | 10.47% | 0.00% |
| Feb. 10, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | F | Common Stock | 1127 | $468.41 | 21,811.0000 | 258,000,000 | 4.91% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | A | Common Stock | 4720 | $0.00 | 20,858.0000 | 258,000,000 | 29.25% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | McKechnie Duncan | EVP, Chief Commercial Officer | A | Common Stock | 2080 | $0.00 | 22,938.0000 | 258,000,000 | 9.97% | 0.00% |